Skip to Main Content
Phase I-II

A Phase 1b, Multicenter, Open-Label, Single-arm Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) in Participants Aged 12 to 75 Years for the Treatment of Focal-Onset Seizures

  • Study IRB#:2000041219
  • Last Updated:10/06/2026

    Contact Us

    For more information about this study, including how to volunteer, contact:

    Danielle Carlson

    Help Us Discover!

    You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877-978-8343 for more information.

    Principal Investigator

    For more information about this study, including how to volunteer, contact: